DNM1L and Parkinson disease: The pharmacological inhibition of DRP1 by mitochondrial division inhibitor (Mdivi-1) in PD rats not only significantly alleviates behavioural deficits but also modulates mitochondrial function, enhances biogenesis and boosts the production of new-born dopaminergic neurons in the substantia nigra pars compacta [176].